Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial

Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1375-84.

Abstract

Background and objectives: It cannot be excluded that supplementation with L-arginine, by improving function of endothelium and hypotensive effect, can be advantegeous in prevention of cardiovascular diseases in healthy people. However, reports about hypotensive effect of L-arginine in healthy people are unclear. Moreover, no research including ambulatory blood pressure measurement (ABPM) has been conducted so far. Therefore, the aim of our study was to show if 4-week supplementation of healthy people with L-arginine influences blood pressure measured with ABPM.

Materials and methods: The study was carried out on 19 healthy people randomized to 6 g/24-hour, 12 g/24-hours of L-arginine or placebo. ABPM was carried out 4 times: before randomization, after 2 and 4 weeks of supplementation and 2 weeks after finishing supplementation.

Results: It was found that 4 weeks of supplementation of healthy people with L-arginine (6 or 12 g/24-hour) led to nonsignificant decrease of systolic and diastolic blood pressure; the decrease was greater during night.

Conclusion: These findings showed that supplementation with L-arginine is not necessarily advantageous in healthy people.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arginine / administration & dosage
  • Arginine / pharmacology*
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory
  • Dietary Supplements*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Time Factors

Substances

  • Arginine